Efficacy of ethane-1-hydroxy-1,1-bisphosphonate (EHBP) for the decorporation of uranium after intramuscular contamination in rats

International Journal of Radiation Biology

Volumn 75, Issue 11, 1999, Pages 1473-1477

  Henge Napoli, M H ^a   Ansoborlo, E ^a   Chazel, V ^a   Houpert, P ^a   Paquet, F ^a   Gourmelon, P ^a  

^a INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE IRSN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ETIDRONIC ACID; URANIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHELATION; CONTROLLED STUDY; DRUG EFFICACY; INTRAMUSCULAR DRUG ADMINISTRATION; KIDNEY; MALE; NONHUMAN; NUCLEAR ACCIDENT; PRIORITY JOURNAL; RADIOACTIVE CONTAMINATION; RAT;

EID: 0032727581     PISSN: 09553002     EISSN: None     Source Type: Journal    
DOI: 10.1080/095530099139331     Document Type: Article

References (19)

1. BASINGER, M. A. and JONES, M. M., 1981, Tiron (sodium 4,5-dihydrobenzene-1,3-disulfonate) as an antidote for acute uranium intoxication in mice. Research Communications in Chemical Pathology and Pharmacology, 34, 351-358.
2. BHATTACHARYA, M. H., BREITENSTEIN, B., METIVIER, H., MUGGENBURG, B. A., STRADLING, G. N. and VOLF, V., 1992, Guidebook for the treatment of accidental internal radionuclide contamination of workers. Radiation Protection Dosimety, 41, 27-36.
3. DOMINGO, J. L., ORTEGA, A., LLOBET, J. M. and CORBELLA, J., 1990, Effectiveness of chelation therapy with time after acute uranium intoxication. Fundamental and Applied Toxicology, 14, 88-95.
4. DOMINGO, J. L., ORTEGA, A., LLOBET, J. M., PATERNAIN, J. L. and CORBELLA, J., 1989, The effects of repeated parenteral administration of chelating agents on the distribution and excretion of uranium. Research Communications in Chemical Pathology and Pharmacology, 64, 161-164.
5. DURBIN, P. W., KULLGREN, B., Xu, J. and RAYMOND, K. N., 1994, In vivo chelation of Am (III), Pu (IV), Np (V) and U (VI) in mice by Tren-(Me-3,2-HOPO). Radiation Protection Dosimetry, 53, 305-309.
6. DURBIN, P. W., KULLGREN, B., Xu, J. and RAYMOND, K. N., 1997, New agents for in vivo chelation of U (VI): efficacy and toxicity in mice of multidemate catecholate and hydroxypyridonate ligands. Health Physics, 72, 865-879.
7. DURBIN, P. W., KULLGREN, B., Xu, J. and RAYMOND, K. N., 1998, Development of decorporation agents for the actinides. Radiation Protection Dosimetry, 79, 433-443.
8. FRANCIS, R. M., 1995, Oral bisphosphonates in the treatment of osteoporosis: a review. Current Therapeutic Research, 56, 831-851.
9. GRAY, S. A., STRADLING, G. N., PEARCE, M. J., WILSON, I., MOODY, J. C., BURGADA, R., DURBIN, P. W. and RAYMOND, K. N., 1994, Removal of plutonium and americium from the rat using 3,4,3-LIHOPO and DTPA after simulated wound contamination: effect of delayed administration and mass of plutonium. Radiation Protection Dosimetry, 53, 319-322.
10. HENGE-NAPOLI, M. H., ANSOBORLO, E., HOUPERT, P., MIRTO, H., PAQUET, F., BURGADA, R., HODGSON, S. and STRADLING, G. N., 1998, Progress and trends in in vivo chelation of uranium. Radiation Protection Dosimetry, 79, 449-452.
11. HENGE-NAPOLI, M. H., ARCHIMBAUD, M., ANSOBORLO, E., METIVIER, H. and GOURMELON, P., 1995, Efficacy of 3,4,3-LIHOPO for reducing the retention of uranium in rat after acute administration. International Journal of Radiation Biology, 68, 389-393.
12. HODGE, H. C., 1973, A history of uranium poisoning (1824 1942). In Uranium, Plutonium, Transplutonic Elements, edited by H. C. Hodge and J. B. Hursh (New York: Springer-Verlag), pp. 165-196.
13. MCNIDER, W. DE B., 1916, The inhibition of toxicity of uranium nitrate by sodium carbonate, and the protection of the kidney acutely nephropathic from uranium or from the toxic action of an anesthesic by sodium carbonate. Journal of Experimental Medicine, 23, 171-187.
14. METIVIER, H., 1994, CEC-USDOE Guidebook for the treatment of internal contamination of workers: an overview. Radiation Protection Dosimetry, 53, 291-295.
15. PASQUIER, C., MESTRIES, J. C. and CARAIANNIS, M., 1979, Traitement des contaminations aiguës à l'uranium. Essai de l'acétazolamide. C.R.S.S.A. 79, Travaux Scientifiques, no. 1, 148-150.
16. PASQUIER, M. and BOURGUIGNON, M. C., 1977, Thérapeutique des contaminations par l'uranium. C.R.S.S.A. 76, Travaux Scientifiques, no. 6, 149-154.
17. STRADLING, G. M., GRAY, S. A., MOODY, J. C. and ELLENDER, M., 1991, Efficacy of Tiron for enhancing the excretion of uranium from the rat. Human and Experimental Toxicology, 10, 195-198.
18. UBIOS, A. M., BRAUN, E. M. and CABRINI, R. L., 1994, Lethality due to uranium poisoning is prevented by ethane-1-hydroxy-1,1,diphosphonate (EHDP). Health Physics, 66, 540-544.
19. UBIOS, A. M., GUGLIELMOTTI, M. B. and CABRINI, R. L., 1990, Ethane-1-hydroxy-1,1,diphosphonate (EHDP) counter-acts the inhibitory effect of uranyl nitrate on bone formation. Archives of Environmental Health, 45, 376-377.